
Megabrith 200mg Tablet SR
Marketer
Globus Labs
Salt Composition
Acebrophylline (200mg)
Overview Megabrith 200mg Tablet SR
Broncho-Relief 200mg Extended-Release Tablets manage and prevent asthma, bronchitis, and chronic obstructive pulmonary disease (COPD) symptoms. By relaxing airway muscles, it improves airflow, easing breathing. Broncho-Relief 200mg ER tablets should be taken with an evening meal, consistently at the same time daily for optimal effectiveness. Dosage and frequency vary depending on the condition; your physician will determine the appropriate regimen to alleviate your symptoms. Continue taking this medication as prescribed. If a dose is missed, take it as soon as possible, or if significantly late, omit the missed dose and resume the regular schedule. This medication doesn't provide immediate relief or prevent acute breathing issues; carry your rescue inhaler for emergencies. Common side effects include stomach upset, bloating, nausea, vomiting, diarrhea, constipation, and heartburn. Report any concerning side effects to your doctor; management strategies may be available. Avoid alcohol and smoking during treatment. Before starting, inform your doctor about any kidney, liver, or heart conditions, and all other medications you're taking, as interactions may affect efficacy or function. Disclose pregnancy or breastfeeding status prior to commencing treatment.
Primary Ingredients of Megabrith 200mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Megabrith 200mg Tablet SR
Asthma, bronchitis, and chronic obstructive pulmonary disease (COPD) management.
Major Benefits of Megabrith 200mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Megabrith 200mg Tablet SR whole; do not crush, chew, or break it. Administer this medication with a meal.
Common Side effects of Megabrith 200mg Tablet SR:
- Vomiting
- Abdominal pain
- Drowsiness
- Heartburn
- Increased white blood cell count
- Loss of appetite
- Rash
- Itching
- Constipation
- Diarrhea
- Abdominal discomfort
- Abdominal distension
- Esophageal bleeding
- Red spots or bumps
- Breathing problems
- High white blood cell count
- Nasal inflammation
How to use Megabrith 200mg Tablet SR:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Megabrith 200mg Sustained-Release tablet should be administered with a meal.
How Megabrith 200mg Tablet SR works:
Brespure 200mg Extended-Release Tablets combine mucolytic and bronchodilatory actions. This medication facilitates easier breathing by relaxing airway muscles and reducing mucus viscosity, thereby promoting its expulsion.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Megabrith 200mg sustained-release tablets and alcohol can lead to significant drowsiness.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Megabrith 200mg sustained-release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Megabrith 200mg sustained-release tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Megabrith 200mg sustained-release tablets.
KidneyCAUTION
Patients with kidney impairment should use Megabrith 200mg sustained-release tablets cautiously. Dosage modification of Megabrith 200mg sustained-release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Megabrith 200mg sustained-release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Megabrith 200mg Tablet SR :
Should you forget a Megabrith 200mg Tablet SR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Megabrith 200mg Tablet SR
| Label | Value |
|---|---|
| Chemical Classification | Methylxanthines |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Actions | Theophylline-based medications |
